Visual Features for Neural Representations of Location
Trial Summary
What is the purpose of this trial?
How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one needs to direct their attention to different locations. One prominent theory about how one accomplishes this claims that important locations are identified based on distinct feature types (for example, motion or color), with locations most unique compared to the background most likely to be attended. An important component of this theory is that individual feature dimensions (again, color or motion) are computed within their own 'feature maps', which are thought to be implemented in specific brain regions. However, whether and how specific brain regions contribute to these feature maps remains unknown. The goal of this study is to determine how brain regions that respond strongly to different feature types (color and motion) and which encode spatial locations of visual stimuli transform 'feature dimension maps' based on stimulus properties as a function of task instructions. The investigators hypothesize that feature-selective brain regions act as neural feature dimension maps, and thus encode representations of relevant location(s) based on their preferred feature dimension, such that the stimulus representation in the most relevant feature map is up-regulated to support adaptive behavior. The investigators will scan healthy human participants using functional MRI (fMRI) in a repeated-measures design while they view visual stimuli made relevant based on a cued feature dimension (e.g., color or motion). The investigators will employ state-of-the-art multivariate analysis techniques that allow them to reconstruct an 'image' of the stimulus representation encoded by each brain region to dissect how neural tissue identifies salient locations. Each participant will perform a challenging discrimination task based on the cued feature (report motion direction or color of stimulus dots) of a stimulus presented in the periphery, which are identical across trial types. Across trials the investigators will manipulate the attended feature value (color, motion, or fixation point). This manipulation will help the investigators fully understand these critical relevance computations in the healthy human visual system.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Stimulus properties: task-defining feature?
Research suggests that visual memory can be formed without specific spatial details, and certain neurons in the brain can recognize objects regardless of changes in size, position, or angle. This indicates that focusing on specific features, like color, can help in accurately identifying and remembering visual targets, which supports the idea that task-defining features can enhance visual processing and memory.12345
How does the treatment 'Stimulus properties: task-defining feature' differ from other treatments for visual location representation?
This treatment is unique because it focuses on the specific visual features that define a task, rather than relying on spatial location information. It explores how visual events can be remembered without precise spatial coordinates, which is different from traditional methods that emphasize spatial location in visual processing.16789
Research Team
Tommy C Sprague
Principal Investigator
University of California, Santa Barbara
Eligibility Criteria
This trial is for healthy individuals interested in how the brain processes visual information. Participants should be willing to undergo fMRI scans and perform visual tasks that involve discriminating colors or motion of stimuli. Specific eligibility criteria are not provided, but typically participants would need to have no contraindications to fMRI.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Anatomical & Retinotopic Mapping
Participants undergo anatomical and retinotopic mapping to identify brain regions for further analysis
Experimental fMRI Sessions
Participants engage in visual attention tasks during fMRI scanning to study feature dimension maps
Follow-up
Participants are monitored for safety and effectiveness after the experimental sessions
Treatment Details
Interventions
- Stimulus properties: task-defining feature
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Santa Barbara
Lead Sponsor
National Eye Institute (NEI)
Collaborator